Kobo Biotech

Kobo_Biotech02 May 2024

Pharmaceuticals

₹

+0.18 (+4.47%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Kobo Biotech

Kobo Biotech

Pharmaceuticals

Kobo_Biotech02 May 2024

₹

+0.18 (+4.47%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
30-May-2012	D	Avon Organics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has recommended a dividend of Re. 1/- i.e. 10% per equity share of Rs. 10/- each for the financial year ended March 31, 2012, subject to the approval of shareholders of the Company.	21-Sep-2012
19-May-2011	D	Avon Organics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 19, 2011, inter alia, has recommended a dividend of Re. 1/- i.e. 10% per equity share of Rs 10/- each for the financial year ended March 31, 2011.	22-Jul-2011
13-Aug-2010	D	Avon Organics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 2010, inter alia, has recommended a dividend of Re. 1/- i.e. 10% per equity share of Rs. 10/- each for the financial year ended March 31, 2010.	23-Sep-2010
07-Feb-2024	BC	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the unaudited financial statements for the qu	14-Feb-2024
11-Aug-2023	BC	The board of director of the Company has approved the proposal for re-appointment of Ms. Urja Shah as an independent Director for 2nd term of five years subject to the approval of the members.	27-Dec-2023
03-Nov-2023	BC	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the unaudited financial result for the 2nd Qu	10-Nov-2023
09-Sep-2023	BC	Notice of the 30th Annual General Meeting of the Company for the Financial Year 2022-23 to be held on Saturday, the 30th day of September 2023 at 10.00 A.M. Newspaper advertisement - Disclosure un	30-Sep-2023
03-Aug-2023	BC	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve This is to inform you that a meeting of the B	11-Aug-2023

No Rights has been declared by Kobo_Biotech

Book Closure

Record Date	Split Date	Purpose
14-Feb-2024	-	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the unaudited financial statements for the qu
27-Dec-2023	-	The board of director of the Company has approved the proposal for re-appointment of Ms. Urja Shah as an independent Director for 2nd term of five years subject to the approval of the members.
10-Nov-2023	-	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the unaudited financial result for the 2nd Qu
30-Sep-2023	-	Notice of the 30th Annual General Meeting of the Company for the Financial Year 2022-23 to be held on Saturday, the 30th day of September 2023 at 10.00 A.M. Newspaper advertisement - Disclosure un
11-Aug-2023	-	Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve This is to inform you that a meeting of the B

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Kobo Biotech Ltd ₹4.21(+0.18/4.47%)	4.21	+0.18	10.03	63.81	0.00	-0.08
Astrazeneca Pharma India Ltd ₹5,333.85(-7.40/-0.14%)	5,333.85	-7.40	13,334.63	67.79	83.60	20.36
Bliss GVS Pharma Ltd ₹129.20(+5.50/4.45%)	129.20	+5.50	1,352.61	67.42	19.82	1.38
Cipla Ltd ₹1,419.55(+18.35/1.31%)	1,419.55	+18.35	114,613.75	54.95	34.85	4.43
Amrutanjan Health Care Ltd ₹786.60(+88.65/12.70%)	786.60	+88.65	2,274.11	29.81	51.68	8.68
Abbott India Ltd ₹26,604.35(+188.60/0.71%)	26,604.35	+188.60	56,534.24	18.89	49.35	18.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.02	0.00	0.00	0.00
Total Income	0.00	0.00	0.02	0.00	0.00	0.00
Total Expenditure	0.20	0.20	0.23	0.79	0.17	0.21
PBIDT	-0.20	-0.20	-0.21	-0.79	-0.17	-0.21
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.20	-0.20	-0.21	-0.79	-0.17	-0.21
Depreciation	1.03	1.02	1.01	1.00	1.03	0.89
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-1.23	-1.22	-1.23	-1.79	-1.19	-1.10
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-1.23	-1.22	-1.23	-1.79	-1.19	-1.10

EPS (Unit Curr.)	-0.52	-0.51	-0.51	-0.75	-0.50	-0.46
EPS (Adj) (Unit Curr.)	-0.52	-0.51	-0.51	-0.75	-0.50	-0.46
Calculated EPS (Unit Curr.)	-0.52	-0.51	-0.51	-0.75	-0.50	-0.46
Calculated EPS (Adj) (Unit Curr.)	-0.52	-0.51	-0.51	-0.75	-0.50	-0.46
Calculated EPS (Ann.) (Unit Curr.)	-2.07	-2.04	-2.06	-3.01	-2.00	-1.85
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-2.07	-2.04	-2.06	-3.01	-2.00	-1.85
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	23.83	23.83	23.83	23.83	23.83	23.83
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	23.83	23.83	23.83	23.83	23.83	23.83
Reserves Total	-151.81	-146.25	-131.03	-111.80	-90.79	-66.33
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-127.98	-122.42	-107.20	-87.97	-66.96	-42.50
Secured Loans	108.13	109.00	228.82	219.05	204.65	190.25
Unsecured Loans	31.71	31.71	31.71	31.71	31.71	31.71
Total Debt	139.84	140.71	260.53	250.76	236.36	221.96
Total Liabilities	11.86	18.29	153.33	162.79	169.40	179.46
APPLICATION OF FUNDS :
Gross Block	103.68	103.68	192.42	192.42	192.42	192.41
Less : Accumulated Depreciation	66.09	62.02	135.51	129.88	124.00	117.85
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	37.59	41.66	56.91	62.54	68.42	74.56
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	2.25	2.25	2.25	2.25
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	12.19	12.19	12.19	12.19
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	18.04	18.04	53.28	53.28	53.28	55.46
Sundry Debtors	11.95	11.80	92.47	93.29	90.61	88.83
Cash and Bank	0.13	0.13	1.56	0.13	0.13	0.13
Loans and Advances	7.62	7.56	11.92	12.65	12.56	12.51
Total Current Assets	37.74	37.53	159.23	159.34	156.58	156.93
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	58.51	55.95	71.79	68.44	64.94	61.38
Provisions	0.19	0.18	0.37	0.00	0.00	0.00
Total Current Liabilities	58.70	56.13	72.16	68.44	64.94	61.38
Net Current Assets	-20.96	-18.60	87.07	90.90	91.63	95.55
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	2.99	2.99	2.99	2.99	2.99	2.99
Net Deferred Tax	-2.99	-2.99	-2.99	-2.99	-2.99	-2.99
Total Assets	13.64	20.07	155.43	164.89	171.50	181.56
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.13	1.56	0.13	0.13	0.13
Net Cash from Operating Activities	0.87	93.76	2.51	14.48	20.95
Net Cash Used In Investing Activities	0.00	25.09	0.00	0.00	0.00
Net Cash Used In Financing Activities	-0.87	-120.28	-1.08	-14.47	-20.95
Net Inc./Dec In Cash And Cash Equivalents	0.00	-1.43	1.43	0.00	0.00
Cash And Cash Equivalents At End Of The Year	0.13	0.13	1.56	0.13	0.13

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

44.95%

FII Shareholding

0.00%

DII Shareholding

0.66%

Public Shareholding

54.39%

**Promoter pledged shareholding 44.95%

About Kobo Biotech Ltd

Kobo Biotech Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 10.03 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -1.23 crores for the quarter ended December 2018. The company management includes Ajit Kamath, Ajit Kamath,Rajendra Kaimal,Jignesh Patel,Sunil Pitroda,Abhishek Buddhadev,Urja Shah (Kobo Biotech Ltd) among others.

Chairman

Ajit Kamath

Registered office

Ground Flr D No 8-2-684/J/8/A,Bhavani Nagar Banjara Hills,Hyderabad,Telangana,500034

FAX :

Background

Incorporation Year1993

Face Value₹10

Market Lot1

How to buy Kobo Biotech shares on nse?

To buy Kobo Biotech shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Kobo Biotech share price today?

The Kobo Biotech shares price on nse is Rs.4.21 today.

What is the market cap of Kobo Biotech shares on BSE ?

The company has a market capitalization of Rs.10.03Cr

What is the PE & PB ratio of Kobo Biotech shares ?

PE is 0 and PB is -0.08

What is the 52 Week High and Low of Kobo Biotech shares?

Kobo Biotech stock price high: Rs.6.01 Kobo Biotech stock price low: Rs.2.04